TrialBMJ open2015

RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial.

Laura Jopson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.